{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:10:51Z","timestamp":1788469851181,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008697","name":"University of Karachi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijbiomac.2024.133841","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T16:05:33Z","timestamp":1721318733000},"page":"133841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"P2","title":["Cellulose ether and carbopol 971 based gastroretentive controlled release formulation design, optimization and physiologically based pharmacokinetic modeling of ondansetron hydrochloride minitablets"],"prefix":"10.1016","volume":"276","author":[{"given":"Tahmina","family":"Maqbool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia Ismail","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh Rafiq","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Harris","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faaiza","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Sarfaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Adnan","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar Alam","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/17425247.5.6.681","article-title":"Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations","volume":"5","author":"Kagan","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.133841_bb0010","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijbiomac.2012.07.030","article-title":"Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software","volume":"51","author":"Hooda","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115617","article-title":"Natural polysaccharides for controlled delivery of oral therapeutics: a recent update","volume":"230","author":"Layek","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.133841_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/10837450.2020.1720235","article-title":"Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI","volume":"25","author":"Abd El-Aziz","year":"2020","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133841_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/03639045.2019.1711387","article-title":"Assessment of the effect of polymers combination and effervescent component on the drug release of swellable gastro-floating tablet formulation through compartmental modeling-based approach","volume":"46","author":"Choiri","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133841_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0250-474X.62237","article-title":"Multiparticulate system for colon targeted delivery of ondansetron","volume":"72","author":"Jose","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0035","doi-asserted-by":"crossref","unstructured":"K. Deshmukh, M. Basheer Ahamed, R.R. Deshmukh, S.K. Khadheer Pasha, P.R. Bhagat, K. Chidambaram, 3 - Biopolymer Composites With High Dielectric Performance: Interface Engineering, in: K.K. Sadasivuni, D. Ponnamma, J. Kim, J.J. Cabibihan, M.A. AlMaadeed (Eds.), Biopolymer Composites in Electronics, Elsevier2017, pp. 27\u2013128.","DOI":"10.1016\/B978-0-12-809261-3.00003-6"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0040","series-title":"Modern Biopolymer Science","first-page":"519","article-title":"CHAPTER 16 - biopolymers in controlled-release delivery systems","author":"Pal","year":"2009"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133841_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-5173(01)00937-1","article-title":"Consistency of Carbopol 971-P NF gels and influence of soluble and cross-linked PVP","volume":"233","author":"Sanz Taberner","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133841_bb0050","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3109\/03639045.2010.545068","article-title":"Evaluation of hydrophilic matrix tablets based on Carbopol\u00ae 971P and low-viscosity sodium alginate for pH-independent controlled drug release","volume":"37","author":"Al-Zoubi","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2024.133841_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2009.10.015","article-title":"Development of swelling\/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism","volume":"39","author":"Chen","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133841_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116914","article-title":"Swelling\/floating capability and drug release characterizations of Gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium Carboxymethyl cellulose","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0065","first-page":"9","article-title":"Ondansetron metabolism and pharmacokinetics","author":"Pritchard","year":"1992","journal-title":"Semin. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.133841_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(15)70061-6","article-title":"Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial","volume":"16","author":"Kang","year":"2015","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133841_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-199529020-00004","article-title":"Ondansetron clinical pharmacokinetics","volume":"29","author":"Roila","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0080","doi-asserted-by":"crossref","unstructured":"A. Anilkumar, T.E.G.K. Murthy, A.P. Rani, Hydroxypropyl-\u03b2-Cyclodextrin (HBC) multicomponent complexation and pH independent controlled release delivery system to improved dissolution and oral bioavailability of ondansetron HCI, Indian J. Pharm. Educ 50 (2016) 665\u2013675.","DOI":"10.5530\/ijper.50.4.19"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133841_bb0085","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.xphs.2019.05.033","article-title":"Biowaiver monograph for immediate-release solid Oral dosage forms: ondansetron","volume":"108","author":"Rajawat","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133841_bb0090","first-page":"567","article-title":"Design and development of ondansetron hydrochloride pH independent control released matrix tablets","volume":"33","author":"Anilkumar","year":"2020","journal-title":"Pak. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133841_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/03639045.2020.1716372","article-title":"Sustained release formulation of ondansetron HCl using osmotic drug delivery approach","volume":"46","author":"Gundu","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0100","article-title":"Development and characterization of polymeric nanoparticles containing ondansetron hydrochloride as a hydrophilic drug","volume":"74","author":"\u00d6zdal","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.133841_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14988","article-title":"Bimodal release ondansetron for acute gastroenteritis among adolescents and adults: A randomized clinical trial","volume":"2","author":"Silverman","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","article-title":"Design of experiments (DoE) in pharmaceutical development","volume":"43","author":"Politis","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253391","article-title":"Design, development and optimization of sustained release floating, bioadhesive and swellable matrix tablet of ranitidine hydrochloride","volume":"16","author":"Nigusse","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133841_bb0120","first-page":"327","article-title":"DESIGN AND DEVELOPMENT OF FLOATING TABLETS OF RANITIDINE HYDROCHLORIDE BY USING NATURAL POLYMERS","volume":"4","author":"Ali","year":"2017","journal-title":"INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0125","unstructured":"U.S. Pharmacopeial, M. Convention Inc.: Rockville, USA, . USP 42 - NF 37 The United States Pharmacopeia and National Formulary 2019;, 2019."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0130","doi-asserted-by":"crossref","unstructured":"J. Panda, M.E.B. Rao, S. Swain, C.N. Patra, B.R.J.B.-S.U.J.o.B. Jena, A. Sciences, Formulation development, optimization and characterization of mucoadhesive minitablets of cefuroxime axetil: in vitro, ex vivo and in vivo pharmacokinetic evaluation, 11(1) (2022) 1\u201315.","DOI":"10.1186\/s43088-022-00303-2"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0135","doi-asserted-by":"crossref","unstructured":"M.Z. Khan, R.I. Yousuf, M.H. Shoaib, F.R. Ahmed, M.T. Saleem, F. Siddiqui, S.A.J.J.o.D.D.S. Rizvi, Technology, A hybrid framework of artificial intelligence-based neural network model (ANN) and central composite design (CCD) in quality by design formulation development of orodispersible moxifloxacin tablets: Physicochemical evaluation, compaction analysis, and its in-silico PBPK modeling, 82 (2023) 104323.","DOI":"10.1016\/j.jddst.2023.104323"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0140","unstructured":"USP, 1062 Tablet Compression Characteristics, The United States Pharmacopoeial Convention, Second Supplement to USP 40- NF 35 General Chapters, Silver Spring, MA, USA (2020)."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0145","doi-asserted-by":"crossref","unstructured":"A. Irshad, R.I. Yousuf, M.H. Shoaib, F. Qazi, M.T. Saleem, F. Siddiqui, F.R. Ahmed, R.-u. Rehman, S. Jabeen, S. Farooqi, M.Z. Khan, R. Masood, Effect of starch, cellulose and povidone based superdisintegrants in a QbD-based approach for the development and optimization of Nitazoxanide orodispersible tablets: physicochemical characterization, compaction behavior and in-silico PBPK modeling of its active metabolite Tizoxanide, Journal of Drug Delivery Science and Technology 79 (2023) 104079.","DOI":"10.1016\/j.jddst.2022.104079"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0150","unstructured":"R.C. Rowe, P. Sheskey, M. Quinn, Handbook of Pharmaceutical Excipients, Libros Digitales-Pharmaceutical Press2009."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0155","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.xphs.2017.02.033","article-title":"Insight into a novel strategy for the design of tablet formulations intended for direct compression","volume":"106","author":"Capece","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126409","volume":"251","author":"Husain","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.133841_bb0165","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1021\/js9701061","article-title":"Mechanical properties of compacts and particles that control tableting success","volume":"86","author":"Hiestand","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0170","first-page":"421","article-title":"Studies on direct compression of tablets. VI. Evaluation of methods for the estimation of particle fragmentation during compaction","volume":"19","author":"Duberg","year":"1982","journal-title":"Acta Pharm. Suec."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133841_bb0175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1023\/A:1016214616042","article-title":"The effect of particle fragmentation and deformation on the interparticulate bond formation process during powder compaction","volume":"12","author":"Eriksson","year":"1995","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133841_bb0180","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jps.20262","article-title":"Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction","volume":"94","author":"Tye","year":"2005","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133841_bb0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1023\/A:1011038526805","article-title":"Influence of crystal structure on the tableting properties of sulfamerazine polymorphs","volume":"18","author":"Sun","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0190","first-page":"64","article-title":"The relative densities of pharmaceutical powders, blends, dry granulations, and immediate-release tablets","volume":"27","author":"Hancock","year":"2003","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119023","article-title":"A model to simultaneously evaluate the compressibility and compactibility of a powder based on the compression ratio","volume":"577","author":"Yu","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0200","doi-asserted-by":"crossref","unstructured":"E. RYSHKEWITCH, Compression strength of porous sintered alumina and zirconia, J. Am. Ceram. Soc. 36(2) (1953) 65\u201368.","DOI":"10.1111\/j.1151-2916.1953.tb12837.x"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0205","doi-asserted-by":"crossref","unstructured":"K. Nidhi, K. Uma, J. Sing, A.J.J.o.I.i.A.P.S. Singh, Gastro retentive floating drug delivery system of model drug using central composite design, (2022) 37\u201344.","DOI":"10.37022\/jiaps.v7i1.275"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jsps.2014.02.009","article-title":"Design and evaluation of gastroretentive levofloxacin floating minitablets-in-capsule system for eradication of helicobacter pylori","volume":"22","author":"El-Zahaby","year":"2014","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0215","series-title":"Tablets: Lachman L, Lieberman H, the Theory and Practice of Industrial Pharmacy","author":"Banker","year":"2009"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133841_bb0220","first-page":"1411","volume":"14","author":"Kwon","year":"2022","journal-title":"Novel esomeprazole magnesium-loaded dual-release mini-tablet polycap: formulation, optimization, characterization, and in vivo evaluation in beagle dogs"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0225","unstructured":"USP. Tablet Friability. in USP 43 NF 38 United States Pharmacopeial Convention, Rockville, MD, 2021."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0230","unstructured":"USP. Ondensetron Tablets, USP 43-NF 38, United States Pharmacopeial Convention, Rockville, MD, 2021."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.133841_bb0235","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2018.08.038","article-title":"Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics","volume":"550","author":"Kim","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0240","unstructured":"International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice, Federal register 65(251) (2000) 83041\u201363."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133841_bb0245","first-page":"263","volume":"12","author":"Zhang","year":"2010","journal-title":"Xie, DDSolver: an add-in program for modeling and comparison of drug dissolution profiles"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0250","series-title":"Formulation and Evaluation of Gastro-Retentive Tinidazole Loaded Floating Microsphere for Sustained Release","author":"Kumar","year":"2021"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133841_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133841_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of solute release from porous hydrophilic polymers","volume":"15","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0265","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/DDDT.S131936","article-title":"Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl","volume":"11","author":"El Nabarawi","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0270","first-page":"5217","volume":"14","author":"Farooqi","year":"2020","journal-title":"Development, Therapy, Quality by design (QbD)-based numerical and graphical optimization technique for the development of osmotic pump controlled-release metoclopramide HCl tablets"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0275","doi-asserted-by":"crossref","unstructured":"F. Siddiqui, M.H. Shoaib, F.R. Ahmed, F. Qazi, R.I. Yousuf, M.T. Usmani, M.T. Saleem, K.J.J.o.D.D.S. Ahmed, Technology, Formulation development and optimization of taste-masked azithromycin oral suspension with ion exchange resins: Bioanalytical method development and validation, in vivo bioequivalence study, and in-silico PBPK modeling for the paediatric population, 79 (2023) 104048.","DOI":"10.1016\/j.jddst.2022.104048"},{"issue":"52","key":"10.1016\/j.ijbiomac.2024.133841_bb0280","first-page":"309","article-title":"Stability testing of active pharmaceutical ingredients and finished pharmaceutical products","volume":"10","author":"W.H.O.J.W.E.C.S.P. Prep","year":"2018","journal-title":"Annex"},{"issue":"1\u201324","key":"10.1016\/j.ijbiomac.2024.133841_bb0285","volume":"4","author":"c.s.","year":"2003","journal-title":"Q1A Stability testing of new drug substances and products"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133841_bb0290","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijpharm.2017.09.008","article-title":"Solvent-responsive floating liquid crystalline-molecularly imprinted polymers for gastroretentive controlled drug release system","volume":"532","author":"Zhang","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.133841_bb0295","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/ajhp\/57.11.1046","article-title":"Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion","volume":"57","author":"VanDenBerg","year":"2000","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0300","unstructured":"O. National Center for Biotechnology Information. PubChem Compound Summary for CID 4595, 11\/01\/2024."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0305","doi-asserted-by":"crossref","unstructured":"U. Ezuruike, M. Zhang, A. Pansari, M. De Sousa Mendes, X. Pan, S. Neuhoff, I.J.C.p. Gardner, s. pharmacology, Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator, 11(7) (2022) 805\u2013821.","DOI":"10.1002\/psp4.12791"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0310","doi-asserted-by":"crossref","unstructured":"I.I. Salem, J.M. Ramos L\u00f3pez, A.C. Gal\u00e1n, Ondansetron Hydrochloride, in: H.G. Brittain (Ed.), Analytical Profiles of Drug Substances and Excipients, Academic Press2001, pp. 301\u2013338.","DOI":"10.1016\/S0099-5428(08)60716-9"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0315","doi-asserted-by":"crossref","unstructured":"G.S. Rajawat, T. Belubbi, M.S. Nagarsenker, B. Abrahamsson, R. Cristofoletti, D.W. Groot, P. Langguth, A. Parr, J.E. Polli, M.J.J.o.p.s. Mehta, Biowaiver monograph for immediate-release solid oral dosage forms: ondansetron, 108(10) (2019) 3157\u20133168.","DOI":"10.1016\/j.xphs.2019.05.033"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0320","doi-asserted-by":"crossref","unstructured":"K. Beaumont, I. Gardner, K. Chapman, M. Hall, M.J.J.o.p.s. Rowland, Toward an integrated human clearance prediction strategy that minimizes animal use, 100(10) (2011) 4518\u20134535.","DOI":"10.1002\/jps.22635"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0325","volume":"82","author":"Khan","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133841_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10837450802409404","article-title":"Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes","volume":"14","author":"Krishnaiah","year":"2009","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0335","doi-asserted-by":"crossref","unstructured":"S.S. Jana, M.D. Lad, S. Subramanian, D.P.J.W.J.o.A.R. Sanap, Reviews, Ondansetron: A selective 5HT3 receptor antagonist and it advances in drug delivery system, 16(3) (2022) 068\u2013077.","DOI":"10.30574\/wjarr.2022.16.3.1275"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.133841_bb0345","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2008.03.034","article-title":"A novel approach to sustained pseudoephedrine release: differentially coated minitablets in HPMC capsules","volume":"359","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0350","first-page":"3277","volume":"19","author":"Gong","year":"2018","journal-title":"Development and evaluation of compression coating gastro-floating tablet of alfuzosin hydrochloride for zero-order controlled release"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133841_bb0355","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1208\/s12249-018-1168-z","article-title":"Development and evaluation of compression coating gastro-floating tablet of Alfuzosin hydrochloride for zero-order controlled release","volume":"19","author":"Gong","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0360","first-page":"2606","article-title":"Preparation","volume":"28","author":"Ahmad","year":"2023","journal-title":"Characterization and Evaluation of Flavonolignan Silymarin Effervescent Floating Matrix Tablets for Enhanced Oral Bioavailability"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0365","doi-asserted-by":"crossref","unstructured":"M.H. Shoaib, F.R. Ahmed, R.I. Yousuf, F. Siddiqui, M.T. Saleem, F. Qazi, M.Z. Khan, A. Irshad, L. Bashir, S.J.F.i.P. Naz, SeDeM expert system with I-optimal mixture design for oral multiparticulate drug delivery: An encapsulated floating minitablets of loxoprofen Na and its in silico physiologically based pharmacokinetic modeling, 14 (2023).","DOI":"10.3389\/fphar.2023.1066018"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0370","doi-asserted-by":"crossref","unstructured":"V. Sravya, J. Patro, S.J.W.J.o.P.S. Ch, Formulate gastroretentive floating bioadhesive drug delivery system of nizatidine by direct compression technique: doi:10.54037\/WJPS. 2022.100106, (2022) 59-73.","DOI":"10.54037\/WJPS.2022.100106"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.133841_bb0375","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3109\/03639045.2012.730524","article-title":"Production of extended release minitablets using directly compressible grades of HPMC","volume":"39","author":"Mohamed","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0380","article-title":"Tableting of minitablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions","volume":"2","author":"Lura","year":"2020","journal-title":"International Journal of Pharmaceutics: X"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0385","doi-asserted-by":"crossref","unstructured":"Y.-C. Chen, H.-O. Ho, T.-Y. Lee, M.-T. Sheu, Physical characterizations and sustained release profiling of gastroretentive drug delivery systems with improved floating and swelling capabilities, Int. J. Pharm. 441(1\u20132) (2013) 162\u2013169.","DOI":"10.1016\/j.ijpharm.2012.12.002"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133841_bb0390","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/00986445.2014.891509","article-title":"Swelling kinetics of HPMC tablets","volume":"202","author":"Pedacchia","year":"2015","journal-title":"Chem. Eng. Commun."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2024.133841_bb0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2008.10.021","article-title":"Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets","volume":"36","author":"Virid\u00e9n","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0400","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1211\/0022357023583","article-title":"Influence of dissolution media composition on drug release and in-vitro\/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers","volume":"56","author":"Paroj\u0109i\u0107","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.133841_bb0405","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2005.12.003","article-title":"Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers","volume":"310","author":"Xu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0410","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1208\/s12249-007-9030-8","article-title":"Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics","volume":"9","author":"Ravi","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.133841_bb0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(02)00642-7","article-title":"Effect of HPMC and Carbopol on the release and floating properties of gastric floating drug delivery system using factorial design","volume":"253","author":"Li","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133841_bb0420","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1208\/s12249-016-0696-7","article-title":"The in vitro\/vivo evaluation of prepared gastric floating tablets of Berberine hydrochloride","volume":"18","author":"Ji","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0425","first-page":"695","article-title":"Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets","volume":"9","author":"Kim","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101733","article-title":"Drotaverine hydrochloride gastroretentive floating minitablets: formulation, in-vitro and in-vivo evaluation","volume":"57","author":"Louis","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.133841_bb0440","doi-asserted-by":"crossref","first-page":"13774","DOI":"10.1021\/acsomega.1c01141","article-title":"Zero-order controlled release of water-soluble drugs using a marker pen platform","volume":"6","author":"Li","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0445","doi-asserted-by":"crossref","unstructured":"5-Mathematical models of drug release, in: M.L. Bruschi (Ed.), Strategies to Modify the Drug Release from Pharmaceutical Systems, Woodhead Publishing2015, pp. 63\u201386.","DOI":"10.1016\/B978-0-08-100092-2.00005-9"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133841_bb0455","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"issue":"04","key":"10.1016\/j.ijbiomac.2024.133841_bb0465","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0033-1359421","article-title":"Statistical errors in clinical studies","volume":"02","author":"Slutsky","year":"2013","journal-title":"J Wrist Surg"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0470","doi-asserted-by":"crossref","unstructured":"M.H. Teaima, A.M. El Mohamady, M.A. El-Nabarawi, A.I.J.D.d. Mohamed, i. pharmacy, Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery, 46(5) (2020) 751\u2013761.","DOI":"10.1080\/03639045.2020.1753061"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0475","doi-asserted-by":"crossref","unstructured":"J. Ll\u00e1cer, V. Gallardo, A. Parera, M.J.I.j.o.p. Ruiz, Formation of ondansetron polymorphs, 177(2) (1999) 221\u2013229.","DOI":"10.1016\/S0378-5173(98)00349-4"},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0480","unstructured":"A. Newton, B. Bindu, C.J.J.o.P. Archana, P. Sciences, Comparative Study on Starch Citrate Vs Other Super Disintegrants in the Formulation Characteristics and In vitro Profile of Ondansetron Sublingual Tablets by Direct Compression, (2016)."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133841_bb0485","doi-asserted-by":"crossref","first-page":"2004184","DOI":"10.1002\/advs.202004184","article-title":"Cheerios effect inspired microbubbles as suspended and adhered Oral delivery systems","volume":"8","author":"Zhao","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2024.133841_bb0495","doi-asserted-by":"crossref","unstructured":"G. Vollmer, Disposal of Pharmaceutical Waste in Households\u2013A European Survey, Green and sustainable pharmacy, Springer2010, pp. 165\u2013178.","DOI":"10.1007\/978-3-642-05199-9_11"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.133841_bb0500","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.xphs.2019.03.028","article-title":"Prediction of Ticagrelor and its active metabolite in liver cirrhosis populations using a physiologically based pharmacokinetic model involving pharmacodynamics","volume":"108","author":"Zhang","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.133841_bb0505","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.2042-7158.1996.tb03973.x","article-title":"Clinical pharmacokinetics of ondansetron","volume":"48","author":"Simpson","year":"1996","journal-title":"A review, Journal of pharmacy and pharmacology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133841_bb0510","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-199529020-00004","article-title":"Ondansetron clinical pharmacokinetics","volume":"29","author":"Roila","year":"1995","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133841_bb0515","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/bdd.628","article-title":"Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability","volume":"29","author":"Yang","year":"2008","journal-title":"Biopharm. Drug Dispos."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024046464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024046464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:34:35Z","timestamp":1782765275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024046464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":98,"alternative-id":["S0141813024046464"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133841","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellulose ether and carbopol 971 based gastroretentive controlled release formulation design, optimization and physiologically based pharmacokinetic modeling of ondansetron hydrochloride minitablets","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"133841"}}